The price tag on progress--chemotherapy for colorectal cancer

N Engl J Med. 2004 Jul 22;351(4):317-9. doi: 10.1056/NEJMp048143.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / economics
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / economics
  • Antineoplastic Combined Chemotherapy Protocols / economics*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Camptothecin / economics
  • Cetuximab
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / economics
  • Drug Costs / statistics & numerical data
  • Drug Costs / trends*
  • Humans
  • Irinotecan
  • Medicare
  • Neoplasm Metastasis
  • United States

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Irinotecan
  • Cetuximab
  • Camptothecin